世界の免疫賦活性アジュバント産業:成長傾向・競合分析2019-2025

【英語タイトル】Global Immunostimulatory Adjuvants Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料(DATA909X01196)・商品コード:DATA909X01196
・発行会社(調査会社):QYResearch
・発行日:2019年11月22日
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥651,700見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥977,550見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,303,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界の免疫賦活性アジュバント市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。免疫賦活性アジュバントの種類別には、水酸化アルミニウムアジュバント、ミョウバンアジュバント、リポソーム、その他に、用途別には、病院、医療センター、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・免疫賦活性アジュバントの種類別市場規模:水酸化アルミニウムアジュバント、ミョウバンアジュバント、リポソーム、その他
・免疫賦活性アジュバントの用途別市場規模:病院、医療センター、その他
・免疫賦活性アジュバントの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Bayer、Adjuvance Technologies、Vical、Allergy Therapeutics、BioCentury
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficiency of vaccines as conventional vaccines are highly reactogenic in nature.In 2018, the global Immunostimulatory Adjuvants market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Immunostimulatory Adjuvants.

This study researches the market size of Immunostimulatory Adjuvants, presents the global Immunostimulatory Adjuvants sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Immunostimulatory Adjuvants in key regions like North America, Europe and Asia-Pacific, presents sales, revenue, market share, growth rate of Immunostimulatory Adjuvants for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Adjuvance Technologies
Vical
Allergy Therapeutics
BioCentury

Market Segment by Product Type
Aluminum Hydroxide Adjuvant
Alum Adjuvant
Liposomes
Others

Market Segment by Application
Hospitals
Medical Centers
Others

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Immunostimulatory Adjuvants status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Immunostimulatory Adjuvants manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Immunostimulatory Adjuvants are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Immunostimulatory Adjuvants Market Size Growth Rate by Type
1.3.2 Aluminum Hydroxide Adjuvant
1.3.3 Alum Adjuvant
1.3.4 Liposomes
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Immunostimulatory Adjuvants Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Medical Centers
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Immunostimulatory Adjuvants Market Size
2.1.1 Global Immunostimulatory Adjuvants Revenue 2014-2025
2.1.2 Global Immunostimulatory Adjuvants Sales 2014-2025
2.2 Immunostimulatory Adjuvants Growth Rate by Regions
2.2.1 Global Immunostimulatory Adjuvants Sales by Regions 2014-2019
2.2.2 Global Immunostimulatory Adjuvants Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Immunostimulatory Adjuvants Sales by Manufacturers
3.1.1 Immunostimulatory Adjuvants Sales by Manufacturers 2014-2019
3.1.2 Immunostimulatory Adjuvants Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Immunostimulatory Adjuvants Revenue by Manufacturers (2014-2019)
3.2.2 Immunostimulatory Adjuvants Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Immunostimulatory Adjuvants Market Concentration Ratio (CR5 and HHI)
3.3 Immunostimulatory Adjuvants Price by Manufacturers
3.4 Key Manufacturers Immunostimulatory Adjuvants Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Immunostimulatory Adjuvants Market
3.6 Key Manufacturers Immunostimulatory Adjuvants Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Aluminum Hydroxide Adjuvant Sales and Revenue (2014-2019)
4.1.2 Alum Adjuvant Sales and Revenue (2014-2019)
4.1.3 Liposomes Sales and Revenue (2014-2019)
4.1.4 Others Sales and Revenue (2014-2019)
4.2 Global Immunostimulatory Adjuvants Sales Market Share by Type
4.3 Global Immunostimulatory Adjuvants Revenue Market Share by Type
4.4 Immunostimulatory Adjuvants Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Immunostimulatory Adjuvants Sales by Application

6 North America
6.1 North America Immunostimulatory Adjuvants Breakdown Data by Company
6.2 North America Immunostimulatory Adjuvants Breakdown Data by Type
6.3 North America Immunostimulatory Adjuvants Breakdown Data by Application
6.4 North America Immunostimulatory Adjuvants Breakdown Data by Countries
6.4.1 North America Immunostimulatory Adjuvants Sales by Countries
6.4.2 North America Immunostimulatory Adjuvants Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Immunostimulatory Adjuvants Breakdown Data by Company
7.2 Europe Immunostimulatory Adjuvants Breakdown Data by Type
7.3 Europe Immunostimulatory Adjuvants Breakdown Data by Application
7.4 Europe Immunostimulatory Adjuvants Breakdown Data by Countries
7.4.1 Europe Immunostimulatory Adjuvants Sales by Countries
7.4.2 Europe Immunostimulatory Adjuvants Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Immunostimulatory Adjuvants Breakdown Data by Company
8.2 Asia Pacific Immunostimulatory Adjuvants Breakdown Data by Type
8.3 Asia Pacific Immunostimulatory Adjuvants Breakdown Data by Application
8.4 Asia Pacific Immunostimulatory Adjuvants Breakdown Data by Regions
8.4.1 Asia Pacific Immunostimulatory Adjuvants Sales by Countries
8.4.2 Asia Pacific Immunostimulatory Adjuvants Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Immunostimulatory Adjuvants Breakdown Data by Company
9.2 Central & South America Immunostimulatory Adjuvants Breakdown Data by Type
9.3 Central & South America Immunostimulatory Adjuvants Breakdown Data by Application
9.4 Central & South America Immunostimulatory Adjuvants Breakdown Data by Countries
9.4.1 Central & South America Immunostimulatory Adjuvants Sales by Countries
9.4.2 Central & South America Immunostimulatory Adjuvants Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Immunostimulatory Adjuvants Breakdown Data by Type
10.2 Middle East and Africa Immunostimulatory Adjuvants Breakdown Data by Application
10.3 Middle East and Africa Immunostimulatory Adjuvants Breakdown Data by Countries
10.3.1 Middle East and Africa Immunostimulatory Adjuvants Sales by Countries
10.3.2 Middle East and Africa Immunostimulatory Adjuvants Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Immunostimulatory Adjuvants
11.1.4 Immunostimulatory Adjuvants Product Introduction
11.1.5 Bayer Recent Development
11.2 Adjuvance Technologies
11.2.1 Adjuvance Technologies Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Immunostimulatory Adjuvants
11.2.4 Immunostimulatory Adjuvants Product Introduction
11.2.5 Adjuvance Technologies Recent Development
11.3 Vical
11.3.1 Vical Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Immunostimulatory Adjuvants
11.3.4 Immunostimulatory Adjuvants Product Introduction
11.3.5 Vical Recent Development
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Immunostimulatory Adjuvants
11.4.4 Immunostimulatory Adjuvants Product Introduction
11.4.5 Allergy Therapeutics Recent Development
11.5 BioCentury
11.5.1 BioCentury Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Immunostimulatory Adjuvants
11.5.4 Immunostimulatory Adjuvants Product Introduction
11.5.5 BioCentury Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Immunostimulatory Adjuvants Sales Channels
12.2.2 Immunostimulatory Adjuvants Distributors
12.3 Immunostimulatory Adjuvants Customers

13 Market Forecast
13.1 Global Immunostimulatory Adjuvants Sales and Revenue Forecast 2019-2025
13.2 Global Immunostimulatory Adjuvants Sales Forecast by Type
13.3 Global Immunostimulatory Adjuvants Sales Forecast by Application
13.4 Immunostimulatory Adjuvants Forecast by Regions
13.4.1 Global Immunostimulatory Adjuvants Sales Forecast by Regions 2019-2025
13.4.2 Global Immunostimulatory Adjuvants Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Immunostimulatory Adjuvants Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Immunostimulatory Adjuvants Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Immunostimulatory Adjuvants Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Immunostimulatory Adjuvants Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Immunostimulatory Adjuvants Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Immunostimulatory Adjuvants Product Picture
Table Immunostimulatory Adjuvants Key Market Segments
Table Major Manufacturers Immunostimulatory Adjuvants Covered in This Report
Table Global Immunostimulatory Adjuvants Market Size Growth Rate by Type 2019-2025 (K Pieces) & (Million US$)
Figure Global Immunostimulatory Adjuvants Sales Market Shar by Type 2014-2025
Figure Aluminum Hydroxide Adjuvant Figures
Table Major Manufacturers of Aluminum Hydroxide Adjuvant
Figure Alum Adjuvant Figures
Table Major Manufacturers of Alum Adjuvant
Figure Liposomes Figures
Table Major Manufacturers of Liposomes
Figure Others Figures
Table Major Manufacturers of Others
Table Global Immunostimulatory Adjuvants Market Share by Application 2019-2025 (K Pieces)
Figure Hospitals Use Case
Figure Medical Centers Use Case
Figure Others Use Case
Figure Immunostimulatory Adjuvants Report Years Considered
Figure Global Immunostimulatory Adjuvants Market Size 2014-2025 (Million US$)
Figure Global Immunostimulatory Adjuvants Sales 2014-2019 (K Pieces)
Table Global Immunostimulatory Adjuvants Market Size by Regions 2014-2019 (K Pieces) & (Million US$)
Table Global Immunostimulatory Adjuvants Sales by Regions 2014-2019 (K Pieces)
Table Global Immunostimulatory Adjuvants Sales Market Share by Regions 2014-2019
Figure Global Immunostimulatory Adjuvants Sales Market Share by Regions 2014-2019
Figure Global Immunostimulatory Adjuvants Sales Market Share by Regions in 2018
Table Global Immunostimulatory Adjuvants Revenue by Regions 2014-2019 (Million US$)
Table Global Immunostimulatory Adjuvants Revenue Market Share by Regions 2014-2019
Figure Global Immunostimulatory Adjuvants Revenue Market Share by Regions 2014-2019
Figure Global Immunostimulatory Adjuvants Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Immunostimulatory Adjuvants Sales by Manufacturers (2014-2019) (K Pieces)
Table Global Immunostimulatory Adjuvants Sales Share by Manufacturers (2014-2019)
Figure Global Immunostimulatory Adjuvants Sales Share by Manufacturers in 2018
Table Immunostimulatory Adjuvants Revenue by Manufacturers (2014-2019) (Million USD)
Table Immunostimulatory Adjuvants Revenue Share by Manufacturers (2014-2019)
Figure Immunostimulatory Adjuvants Value Share by Manufacturers in 2018
Table Global Immunostimulatory Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Immunostimulatory Adjuvants Price (2014-2019) (USD/Piece)
Table Key Manufacturers Immunostimulatory Adjuvants Plants/Factories Distribution
Table Key Manufacturers Immunostimulatory Adjuvants Area Served
Table Date of Key Manufacturers Enter into Immunostimulatory Adjuvants Market
Table Key Manufacturers Immunostimulatory Adjuvants Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Aluminum Hydroxide Adjuvant Sales an目录输出!D Revenue (2014-2019) (K Pieces) & (Million US$)
Table Global Alum Adjuvant Sales an目录输出!D Revenue (2014-2019) (K Pieces) & (Million US$)
Table Global Liposomes Sales an目录输出!D Revenue (2014-2019) (K Pieces) & (Million US$)
Table Global Others Sales an目录输出!D Revenue (2014-2019) (K Pieces) & (Million US$)
Table Global Immunostimulatory Adjuvants Sales by Type (2014-2019) (K Pieces)
Table Global Immunostimulatory Adjuvants Sales Share by Type (2014-2019)
Figure Global Immunostimulatory Adjuvants Sales Market Share by Type (2014-2019)
Figure Global Immunostimulatory Adjuvants Sales Market Share by Type in 2018
Table Global Immunostimulatory Adjuvants Revenue by Type (2014-2019) (Million US$)
Table Global Immunostimulatory Adjuvants Revenue Share by Type (2014-2019)
Figure Global Immunostimulatory Adjuvants Revenue Market Share by Type (2014-2019)
Figure Global Immunostimulatory Adjuvants Revenue Market Share by Type in 2018
Table Immunostimulatory Adjuvants Price by Type 2014-2019 (USD/Piece)
Table Global Immunostimulatory Adjuvants Sales by Application (2014-2019) (K Pieces)
Table Global Immunostimulatory Adjuvants Sales Share by Application (2014-2019)
Figure Global Sales Immunostimulatory Adjuvants Market Share by Application (2014-2019)
Figure Global Sales Immunostimulatory Adjuvants Market Share by Application in 2018
Figure North America Immunostimulatory Adjuvants Sales Growth Rate 2014-2019 (K Pieces)
Figure North America Immunostimulatory Adjuvants Revenue Growth Rate 2014-2019 (Million US$)
Table North America Immunostimulatory Adjuvants Sales by Company (2014-2019) (K Pieces)
Table North America Immunostimulatory Adjuvants Sales Market Share by Company (2014-2019)
Figure North America Immunostimulatory Adjuvants Sales Market Share by Company in 2018
Table North America Immunostimulatory Adjuvants Sales by Type (2014-2019) (K Pieces)
Table North America Immunostimulatory Adjuvants Sales Market Share by Type (2014-2019)
Figure North America Immunostimulatory Adjuvants Market Share by Type in 2018
Table North America Immunostimulatory Adjuvants Sales by Application (2014-2019) (K Pieces)
Table North America Immunostimulatory Adjuvants Sales Market Share by Application (2014-2019)
Figure North America Immunostimulatory Adjuvants Market Share by Application in 2018
Table North America Immunostimulatory Adjuvants Sales by Countries (2014-2019) (K Pieces)
Table North America Immunostimulatory Adjuvants Sales Market Share by Countries (2014-2019)
Figure North America Immunostimulatory Adjuvants Sales Market Share by Countries in 2018
Table North America Immunostimulatory Adjuvants Revenue by Countries (2014-2019) (Million US$)
Table North America Immunostimulatory Adjuvants Revenue Market Share by Countries (2014-2019)
Figure North America Immunostimulatory Adjuvants Revenue Market Share by Countries in 2018
Figure United States Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Canada Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Mexico Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Europe Immunostimulatory Adjuvants Sales Growth Rate 2014-2019 (K Pieces)
Figure Europe Immunostimulatory Adjuvants Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Immunostimulatory Adjuvants Sales by Company (2014-2019) (K Pieces)
Table Europe Immunostimulatory Adjuvants Sales Market Share by Company (2014-2019)
Figure Europe Immunostimulatory Adjuvants Sales Market Share by Company in 2018
Table Europe Immunostimulatory Adjuvants Sales by Type (2014-2019) (K Pieces)
Table Europe Immunostimulatory Adjuvants Sales Market Share by Type (2014-2019)
Figure Europe Immunostimulatory Adjuvants Sales Market Share by Type in 2018
Table Europe Immunostimulatory Adjuvants Sales by Application (2014-2019) (K Pieces)
Table Europe Immunostimulatory Adjuvants Sales Market Share by Application (2014-2019)
Figure Europe Immunostimulatory Adjuvants Sales Market Share by Application in 2018
Table Europe Immunostimulatory Adjuvants Sales by Countries (2014-2019) (K Pieces)
Table Europe Immunostimulatory Adjuvants Sales Market Share by Countries (2014-2019)
Figure Europe Immunostimulatory Adjuvants Sales Market Share by Countries in 2018
Table Europe Immunostimulatory Adjuvants Revenue by Countries (2014-2019) (Million US$)
Table Europe Immunostimulatory Adjuvants Revenue Market Share by Countries (2014-2019)
Figure Europe Immunostimulatory Adjuvants Revenue Market Share by Countries in 2018
Figure Germany Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure France Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure UK Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Italy Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Russia Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Asia Pacific Immunostimulatory Adjuvants Sales Growth Rate 2014-2019 (K Pieces)
Figure Asia Pacific Immunostimulatory Adjuvants Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Immunostimulatory Adjuvants Sales by Regions (2014-2019) (K Pieces)
Table Asia Pacific Immunostimulatory Adjuvants Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Immunostimulatory Adjuvants Sales Market Share by Regions in 2018
Table Asia Pacific Immunostimulatory Adjuvants Sales by Type (2014-2019) (K Pieces)
Table Asia Pacific Immunostimulatory Adjuvants Sales Market Share by Type (2014-2019)
Figure Asia Pacific Immunostimulatory Adjuvants Market Share by Type in 2018
Table Asia Pacific Immunostimulatory Adjuvants Sales by Application (2014-2019) (K Pieces)
Table Asia Pacific Immunostimulatory Adjuvants Sales Market Share by Application (2014-2019)
Figure Asia Pacific Immunostimulatory Adjuvants Market Share by Application in 2018
Table Asia Pacific Immunostimulatory Adjuvants Sales by Countries (2014-2019) (K Pieces)
Table Asia Pacific Immunostimulatory Adjuvants Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Immunostimulatory Adjuvants Sales Market Share by Regions in 2018
Table Asia Pacific Immunostimulatory Adjuvants Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Immunostimulatory Adjuvants Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Immunostimulatory Adjuvants Revenue Market Share by Regions in 2018
Figure China Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure China Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Japan Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Korea Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure India Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure India Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Australia Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Indonesia Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Malaysia Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Philippines Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Thailand Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Vietnam Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Immunostimulatory Adjuvants Sales Growth Rate 2014-2019 (K Pieces)
Figure Central & South America Immunostimulatory Adjuvants Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Immunostimulatory Adjuvants Sales by Company (2014-2019) (K Pieces)
Table Central & South America Immunostimulatory Adjuvants Sales Market Share by Company (2014-2019)
Figure Central & South America Immunostimulatory Adjuvants Sales Market Share by Company in 2018
Table Central & South America Immunostimulatory Adjuvants Sales by Type (2014-2019) (K Pieces)
Table Central & South America Immunostimulatory Adjuvants Sales Market Share by Type (2014-2019)
Figure Central & South America Immunostimulatory Adjuvants Market Share by Type in 2018
Table Central & South America Immunostimulatory Adjuvants Sales by Application (2014-2019) (K Pieces)
Table Central & South America Immunostimulatory Adjuvants Sales Market Share by Application (2014-2019)
Figure Central & South America Immunostimulatory Adjuvants Market Share by Application in 2018
Table Central & South America Immunostimulatory Adjuvants Sales by Countries (2014-2019) (K Pieces)
Table Central & South America Immunostimulatory Adjuvants Sales Market Share by Countries (2014-2019)
Figure Central & South America Immunostimulatory Adjuvants Sales Market Share by Countries in 2018
Table Central & South America Immunostimulatory Adjuvants Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Immunostimulatory Adjuvants Revenue Market Share by Countries (2014-2019)
Figure Central & South America Immunostimulatory Adjuvants Revenue Market Share by Countries in 2018
Figure Brazil Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Brazil Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (K Pieces)
Figure Middle East and Africa Immunostimulatory Adjuvants Sales Growth Rate 2014-2019 (K Pieces)
Figure Middle East and Africa Immunostimulatory Adjuvants Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Immunostimulatory Adjuvants Sales by Type (2014-2019) (K Pieces)
Table Middle East and Africa Immunostimulatory Adjuvants Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Immunostimulatory Adjuvants Sales Market Share by Type in 2018
Table Middle East and Africa Immunostimulatory Adjuvants Sales by Application (2014-2019) (K Pieces)
Table Middle East and Africa Immunostimulatory Adjuvants Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Immunostimulatory Adjuvants Sales Market Share by Application in 2018
Table Middle East and Africa Immunostimulatory Adjuvants Sales by Countries (2014-2019) (K Pieces)
Table Middle East and Africa Immunostimulatory Adjuvants Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Immunostimulatory Adjuvants Sales Market Share by Countries in 2018
Table Middle East and Africa Immunostimulatory Adjuvants Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Immunostimulatory Adjuvants Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Immunostimulatory Adjuvants Revenue Market Share by Countries in 2018
Figure GCC Countries Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure GCC Countries Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (K Pieces)
Figure Egypt Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure Egypt Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (K Pieces)
Figure South Africa Immunostimulatory Adjuvants Sales Growth Rate (2014-2019) (K Pieces)
Figure South Africa Immunostimulatory Adjuvants Revenue Growth Rate (2014-2019) (K Pieces)
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2014-2019)
Table Bayer Immunostimulatory Adjuvants Sales Growth Rate (2014-2019)
Table Bayer Immunostimulatory Adjuvants Sales Market Share in Global Market
Table Bayer Recent Development
Table Adjuvance Technologies Company Details
Table Adjuvance Technologies Description and Business Overview
Table Adjuvance Technologies Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2014-2019)
Table Adjuvance Technologies Immunostimulatory Adjuvants Sales Growth Rate (2014-2019)
Table Adjuvance Technologies Immunostimulatory Adjuvants Sales Market Share in Global Market
Table Adjuvance Technologies Recent Development
Table Vical Company Details
Table Vical Description and Business Overview
Table Vical Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2014-2019)
Table Vical Immunostimulatory Adjuvants Sales Growth Rate (2014-2019)
Table Vical Immunostimulatory Adjuvants Sales Market Share in Global Market
Table Vical Recent Development
Table Allergy Therapeutics Company Details
Table Allergy Therapeutics Description and Business Overview
Table Allergy Therapeutics Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2014-2019)
Table Allergy Therapeutics Immunostimulatory Adjuvants Sales Growth Rate (2014-2019)
Table Allergy Therapeutics Immunostimulatory Adjuvants Sales Market Share in Global Market
Table Allergy Therapeutics Recent Development
Table BioCentury Company Details
Table BioCentury Description and Business Overview
Table BioCentury Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2014-2019)
Table BioCentury Immunostimulatory Adjuvants Sales Growth Rate (2014-2019)
Table BioCentury Immunostimulatory Adjuvants Sales Market Share in Global Market
Table BioCentury Recent Development
Figure Immunostimulatory Adjuvants Value Chain
Table Immunostimulatory Adjuvants Distributors List
Table Immunostimulatory Adjuvants Customers List
Table Global Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces) & (Million US$)
Figure Global Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Global Immunostimulatory Adjuvants Revenue Forecast 2019-2025 (Million US$)
Table Global Immunostimulatory Adjuvants Sales Forecast by Type 2019-2025 (K Pieces)
Figure Global Immunostimulatory Adjuvants Sales Forecast by Type 2019-2025 (K Pieces)
Figure Global Immunostimulatory Adjuvants Sales Market Share Forecast by Type 2019-2025
Table Global Immunostimulatory Adjuvants Sales Forecast by Application 2019-2025 (K Pieces)
Figure Global Immunostimulatory Adjuvants Sales Forecast by Application 2019-2025 (K Pieces)
Figure Global Immunostimulatory Adjuvants Sales Market Share Forecast by Application 2019-2025
Table Global Immunostimulatory Adjuvants Sales Forecast by Regions 2019-2025 (K Pieces)
Figure Global Immunostimulatory Adjuvants Sales Forecast by Regions 2019-2025 (K Pieces)
Figure Global Immunostimulatory Adjuvants Sales Market Share Forecast by Regions 2019-2025
Table Global Immunostimulatory Adjuvants Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Immunostimulatory Adjuvants Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Immunostimulatory Adjuvants Revenue Market Share Forecast by Regions 2019-2025
Table North America Immunostimulatory Adjuvants Sales Forecast by Countries 2019-2025 (K Pieces)
Table North America Immunostimulatory Adjuvants Sales Market Share Forecast by Countries 2019-2025
Table North America Immunostimulatory Adjuvants Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Immunostimulatory Adjuvants Revenue Market Share Forecast by Countries 2019-2025
Figure United States Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Canada Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Mexico Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Table Europe Immunostimulatory Adjuvants Sales Forecast by Countries 2019-2025 (K Pieces)
Table Europe Immunostimulatory Adjuvants Sales Market Share Forecast by Countries 2019-2025
Table Europe Immunostimulatory Adjuvants Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Immunostimulatory Adjuvants Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure France Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure UK Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Italy Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Russia Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Table Asia Pacific Immunostimulatory Adjuvants Sales Forecast by Regions 2019-2025 (K Pieces)
Table Asia Pacific Immunostimulatory Adjuvants Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Immunostimulatory Adjuvants Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Immunostimulatory Adjuvants Revenue Market Share Forecast by Regions 2019-2025
Figure China Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Japan Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure South Korea Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure India Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Australia Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Indonesia Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Thailand Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Malaysia Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Philippines Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Vietnam Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Table Central & South America Immunostimulatory Adjuvants Sales Forecast by Countries 2019-2025 (K Pieces)
Table Central & South America Immunostimulatory Adjuvants Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Immunostimulatory Adjuvants Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Immunostimulatory Adjuvants Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Table Middle East and Africa Immunostimulatory Adjuvants Sales Forecast by Regions 2019-2025 (K Pieces)
Table Middle East and Africa Immunostimulatory Adjuvants Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Immunostimulatory Adjuvants Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Immunostimulatory Adjuvants Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure GCC Countries Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure Egypt Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Figure South Africa Immunostimulatory Adjuvants Sales Forecast 2019-2025 (K Pieces)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bayer、Adjuvance Technologies、Vical、Allergy Therapeutics、BioCentury

★調査レポート[世界の免疫賦活性アジュバント産業:成長傾向・競合分析2019-2025] (コード:DATA909X01196)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の免疫賦活性アジュバント産業:成長傾向・競合分析2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆